Market Place
Sourcing Support
Vedere Bio II, unimpressed by preclinical work, shuts down
03 Apr 2023 //
FIERCE BIOTECH
Vedere Bio II Presents Positive New Data Supporting Its Proprietary Platform
19 May 2022 //
PRNEWSWIRE
Vedere Bio II to Present Two Abstracts at the ASGCT 2022 Annual Meeting
02 May 2022 //
PRNEWSWIRE
Vedere Bio II Appoints Martina Schinke, as Vice President, Program Leader
08 Feb 2022 //
PRNEWSWIRE
Novartis adds 2nd biotech to optogenetics gene therapy portfolio
22 Sep 2021 //
FIERCEBIOTECH
Novartis gobbles up another bite-sized optogenetics biotech
21 Sep 2021 //
ENDPTS
Vedere Bio II Launches with $77 M Series A Financing to Develop Next Generation
17 May 2021 //
PRESS RELEASE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.